Study of the potential carcinogenicity of topical drug. Suggestions for a new experimental approach.
D000230:Adenocarcinoma / Q000473:pathology; D000287:Administration, Topical; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000633:toxicity; D001984:Bronchial Neoplasms / Q000473:pathology; D002273:Carcinogens / Q000008:administration & dosage* / Q000633:toxicity*; D003436:Croton Oil / Q000008:administration & dosage / Q000633:toxicity; D005260:Female; D005354:Fibrosarcoma / Q000473:pathology; D007093:Imidazoles / Q000633:toxicity; D007889:Leiomyoma / Q000473:pathology; D008175:Lung Neoplasms / Q000473:pathology; D008224:Lymphoma, Follicular / Q000473:pathology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000473:pathology; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000473:pathology; D008722:Methods; D008748:Methylcholanthrene / Q000008:administration & dosage / Q000633:toxicity; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D010212:Papilloma / Q000139:chemically induced; D012513:Sarcoma, Experimental / Q000473:pathology; D012878:Skin Neoplasms / Q000139:chemically induced / Q000473:pathology; D013160:Splenic Neoplasms / Q000473:pathology; D014520:Urethane / Q000008:administration & dosage / Q000633:toxicity; D014594:Uterine Neoplasms / Q000473:pathology
D000893:Anti-Inflammatory Agents; D002273:Carcinogens; D007093:Imidazoles; D014520:Urethane; D008748:Methylcholanthrene; D003436:Croton Oil